1. Home
  2. VTRS vs AKAM Comparison

VTRS vs AKAM Comparison

Compare VTRS & AKAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • AKAM
  • Stock Information
  • Founded
  • VTRS 1961
  • AKAM 1998
  • Country
  • VTRS United States
  • AKAM United States
  • Employees
  • VTRS N/A
  • AKAM N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • AKAM Business Services
  • Sector
  • VTRS Health Care
  • AKAM Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • AKAM Nasdaq
  • Market Cap
  • VTRS 11.8B
  • AKAM 11.4B
  • IPO Year
  • VTRS N/A
  • AKAM 1999
  • Fundamental
  • Price
  • VTRS $10.61
  • AKAM $74.42
  • Analyst Decision
  • VTRS Hold
  • AKAM Hold
  • Analyst Count
  • VTRS 5
  • AKAM 17
  • Target Price
  • VTRS $10.40
  • AKAM $95.56
  • AVG Volume (30 Days)
  • VTRS 9.5M
  • AKAM 2.2M
  • Earning Date
  • VTRS 08-07-2025
  • AKAM 08-07-2025
  • Dividend Yield
  • VTRS 4.52%
  • AKAM N/A
  • EPS Growth
  • VTRS N/A
  • AKAM N/A
  • EPS
  • VTRS N/A
  • AKAM 2.82
  • Revenue
  • VTRS $14,115,700,000.00
  • AKAM $4,083,251,000.00
  • Revenue This Year
  • VTRS N/A
  • AKAM $5.48
  • Revenue Next Year
  • VTRS $1.85
  • AKAM $5.23
  • P/E Ratio
  • VTRS N/A
  • AKAM $26.38
  • Revenue Growth
  • VTRS N/A
  • AKAM 3.98
  • 52 Week Low
  • VTRS $6.85
  • AKAM $67.51
  • 52 Week High
  • VTRS $13.55
  • AKAM $106.80
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 72.50
  • AKAM 44.90
  • Support Level
  • VTRS $8.74
  • AKAM $69.78
  • Resistance Level
  • VTRS $9.03
  • AKAM $75.55
  • Average True Range (ATR)
  • VTRS 0.32
  • AKAM 2.30
  • MACD
  • VTRS 0.17
  • AKAM -0.11
  • Stochastic Oscillator
  • VTRS 90.83
  • AKAM 43.65

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About AKAM Akamai Technologies Inc.

Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.

Share on Social Networks: